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E D I T O R I A L
Editorial foreword: Angiogenesis: Cells, tissues and organs
On the occasion of his 90th birthday, this Special Issue is dedi‐
cated to Professor Robert Auerbach. Born 1929 in Berlin, Germany, 
he and his family escaped Nazi Germany in 1939 and emigrated 
to the United States, where he became a zoologist and ultimately 
Professor and Director of the Developmental Biology Training 
Program at the Department of Zoology, Madison, University of 
Wisconsin, USA. In Auerbach's laboratory, students and scientists 
of many different nations, including politically persecuted ones, 
harmoniously worked together on different aspects of angiogene‐
sis. One of the hallmarks of Auerbach's career as a scientist was and 
is his generosity towards others, sharing his equipment and ideas 
freely, his integrity and his collegiality. His significant contributions 
to angiogenesis and tumour research include the finding that angio‐
genesis in tumours can occur even after their irradiation (Auerbach, 
Arensman, Kubai, & Folkman, 1975) and an explanation of organ 
selectivity in the spread of metastasizing cancer cells (Auerbach, 
1988). Through his outstanding papers on in vitro methods in 
angiogenesis research, he also supported animal welfare (Alby & 
Auerbach, 1984; Auerbach, Lewis, Shinners, Kubai, & Akhtar, 2003; 
Gumkowski, Kaminska, Kaminski, Morrissey, & Auerbach, 1987; 
Obeso, Weber, & Auerbach, 1990).
Angiogenesis, the sprouting of new blood vessels from pre‐ex‐
isting ones, is essential in prenatal development, growth and repair, 
but also contributes to pathological processes. In the healthy adult, 
it plays a significant role in the female ovulation cycle and in preg‐
nancy, hair growth, exercise‐induced growth of skeletal muscle and 
wound repair (Carmeliet, 2003; Olfert, Baum, Hellsten, & Egginton, 
2016). There are only a few locations in the healthy body devoid of 
blood vessels such as the epidermis, cartilage, as well as the lens 
and cornea of the eye. In these organs and tissues, angiogenesis 
occurs only under pathological situations; for example, angiogen‐
esis in hyaline cartilage is a characteristic of osteoarthritic joints 
(Bonnet & Walsh, 2005). However, it is its fundamental role in can‐
cer growth and metastasis that has led to the tremendous interest 
in angiogenesis.
Current research on angiogenesis began in the 1970s when 
Judah Folkman (1933–2008) hypothesized that the growth of tu‐
mours is dependent on angiogenesis. He postulated that in order to 
survive and grow, tumours require blood vessels, and that by cutting 
off that blood supply, cancer could be starved into remission (Ribatti, 
2008; Folkman, 1971). In 1975, Robert Auerbach, who worked with 
Folkman, grafted gamma‐irradiated tumour cells into the chicken 
chorioallantoic membrane as well as into the cornea of adult rabbits. 
These experiments demonstrated that tumour‐induced angiogene‐
sis can occur even after their irradiation and led to the statement: 
“Our results provide additional support for the notion that tumour 
angiogenesis may be quite unique and that the approach to tumour 
control by interference with angiogenesis may well be a profitable 
one.” Auerbach, Folkman and colleagues published their pioneering 
work in 1975 (Auerbach et al., 1975) and thus inaugurated a new 
era of intensive research into angiogenesis (McCain & Salter, 2007) 
based on the idea that anti‐angiogenesis may be a method to control 
the growth of a tumour.
Subsequently, many cellular and molecular mechanisms involved 
in angiogenesis in health and disease have been identified (D'Alessio, 
Moccia, Li, Micera, & Kyriakides, 2015). Additionally, new therapeu‐
tic strategies have been developed based upon pro‐ and anti‐angio‐
genesis for a variety of diseases, including some forms of cancer.
However, even with all its successes, there have been scenarios 
where angiogenesis research has not lived up to the high expecta‐
tions placed upon it; for example, anti‐angiogenic tumour therapy 
has not been as successful as initially hoped. One reason for this 
is that alternate mechanisms of neovascularization such as vascular 
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mimicry exist (Ge & Luo, 2018). For example, vascular mimicry is uti‐
lized by highly aggressive cancer cells as found in glioblastomas to 
generate vascular‐like structures promoting tumour growth (Angara, 
Borin, & Arbab, 2017). The role of vascular mimicry in tumour pro‐
gression still needs to be studied in more detail in order to translate 
new findings into therapeutic strategies.
Apart from journals specialized on the topic of angiogenesis like 
“Angiogenesis,” over the past years, several special issues in promi‐
nent international fora have been devoted to angiogenesis research. 
For example, the journal “Investigational New Drugs” published a 
special issue on “Development of angiogenesis inhibitors for can‐
cer therapy” in 1997 (Volume 15, Issue 1, 1997 ISSN: 0167‐6997). 
“Cancer Letters” circulated a special issue on "Angiogenesis‐conver‐
gent or divergent, that is the question: Research toward targeted 
strategies in oncology" (Cai, 2016).
More recently, a special issue of the journal “BioMed Research 
International” highlighted “The Role of Endothelium in Physiological 
and	Pathological	States”	(Stanek,	Fazeli,	Bartuś,	&	Sutkowska,	2018).
The present special issue presents the results and views of sci‐
entists working in the fields of veterinary anatomy, histology and 
embryology on “Angiogenesis: Cells, Tissues and Organs.” I would 
like to sincerely thank all colleagues who supported this issue with 
their contributions.
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